论著

安徽地区胆汁淤积性肝病病理学病因分析

展开
  • 1.中国科学技术大学附属第一医院感染病科,安徽 合肥 230002
    2.安庆市立医院感染性疾病科,安徽 安庆 246003
    3.蚌埠医学院第一附属医院感染病科,安徽 蚌埠 233099
    4.阜阳市第二人民医院肝病科,安徽 阜阳 236029
    5.安徽医科大学第二附属医院感染肝病科,安徽 合肥 230601
    6.黄山市人民医院感染病科,安徽 黄山 245099
    7.亳州市人民医院感染病科,安徽 亳州 236814

收稿日期: 2021-11-21

  网络出版日期: 2022-07-25

Pathological and etiological analysis of cholestatic liver disease in Anhui

Expand
  • 1. Department of Infectious Diseases, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230002, China
    2. Department of Infectious Diseases, Anqing Municipal Hospital, Anqing 246003, China
    3. Department of Infectious Diseases, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233099, China
    4. Department of Hepatology, Fuyang Second People’s Hospital, Fuyang 236029, China
    5. Department of Hepatology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China
    6. Department of Infectious Diseases, Huangshan People’s Hospital, Huangshan 245099, China
    7. Department of Infectious Diseases, Bozhou People’s Hospital, Bozhou 236814, China

Received date: 2021-11-21

  Online published: 2022-07-25

摘要

目的: 探讨不明原因胆汁淤积性肝病患者的病理学病因分布情况。方法: 收集2017年12月至2021年11月安徽地区7所医院收治的139例胆汁淤积起病的不明原因肝功能异常患者的个人信息、临床资料、实验室检查及肝穿刺病理结果,对观察指标进行统计学分析,探明胆汁淤积性肝病患者病理析因的主要分布情况及肝脏穿刺的诊断价值。结果: 139例以胆汁淤积为主要表现的不明原因肝功能异常患者中女性105例,男性34例,平均年龄(50.2±11.5)岁。所有患者全部进行肝穿刺病理学检查,结合临床资料最后明确诊断121例(87.1%),其中自身免疫性肝病85例(61.2%),包括原发性胆汁性胆管炎56例(40.3%),自身免疫性肝炎15例(10.8%),自身免疫性肝炎合并原发性胆汁性胆管炎11例(7.9%);药物性肝损伤21例(15.1%);代谢性脂肪性肝病5例(3.6%);胆管消失综合征2例(1.4%),病因暂不明确18例(12.9%)。自身免疫性肝病组患者的碱性磷酸酶(alkaline phosphatase,ALP)水平明显偏高[291.0(225.0,387.0) U/mL比236.0(181.0,293.5) U/mL,P=0.002]。结论: 胆汁淤积起病的不明原因肝损害以女性居多,疾病谱分布主要为自身免疫性肝病,尤其是原发性胆汁性胆管炎,其次为药物性肝损伤。ALP水平可能可以帮助鉴别患者是否存在自身免疫性肝病。

本文引用格式

宁玲, 刘贞君, 李伟, 刘雯, 李卫, 张振华, 方卫东, 高有方, 郑晓玮, 李磊 . 安徽地区胆汁淤积性肝病病理学病因分析[J]. 内科理论与实践, 2022 , 17(01) : 53 -57 . DOI: 10.16138/j.1673-6087.2022.01.010

Abstract

Objective To explore the pathology and etiology in the patients with cholestatic liver disease.Methods From December 2017 to November 2021, 139 patients with unclarified liver dysfunction manifested as cholestasis were admitted from several hospitals in Anhui province. The clinical data including personal information, laboratory examination and liver biopsy were analyzed. Results Among 139 patients, there were 105 females and 34 males, and the average age was (50.2±11.5) years. All patients underwent liver biopsy, and 121 cases (87.1%) were definitively diagnosed, while the etiology of 18 cases(12.9%) were not clear. One hundred and twenty-one patients were given one or more etiological diagnoses as follows: 85 cases (61.2%) of autoimmune liver disease, 56 cases (40.3%) of primary biliary cholangitis, 15 cases(10.8%) of autoimmune hepatitis, 11 cases(7.9%) of autoimmune hepatitis combined with primary biliary cholangitis, 21 cases (15.1%) of drug-induced liver injury, 5 cases (3.6%) of metabolic fatty liver disease and 2 cases (1.4%) of vanishing bile duct syndrome. In addition, it was found that the alkaline phosphatase(ALP) level in the patients with the autoimmune liver disease was significantly higher [291.0 (225.0, 387.0) U/mL vs. 236.0 (181.0, 293.5) U/mL, P=0.002] than that in other patients.Conclusions Most patients with liver dysfunction and cholestasis were women, and the major diagnosis was autoimmune liver disease, especially primary biliary cholangitis, and the drug-induced liver damage was also one of main causes. ALP could be used to identify whether a patient had autoimmune liver disease.

参考文献

[1] Pollock G, Minuk GY. Diagnostic considerations for cholestatic liver disease[J]. J Gastroenterol Hepatol, 2017, 32(7): 1303-1309.
[2] 沈斐斐, 陆伦根. 胆汁淤积性肝病的病因[J]. 实用肝脏病杂志, 2016, 19(6): 644-646.
[3] 陈小青, 王迎春. 肝内胆汁淤积性肝病的病因与治疗[J]. 实用肝脏病杂志, 2018, 21(2): 163-165.
[4] 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会. 胆汁淤积性肝病诊断和治疗共识(2015)[J]. 临床肝胆病杂志, 2015, 31(12): 1989-1999.
[5] Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis[J]. Lancet, 2015, 386(10003): 1565-1575.
[6] 尧颖. 自身免疫性肝病相关自身抗体的研究进展[J]. 胃肠病学和肝病学杂志, 2019, 28(1): 1188-1191.
[7] 马晓瑞, 李红霞, 马利. 348例药物性肝损害的临床分析[J]. 西安交通大学学报(医学版), 2021, 4 2(6): 909-914.
[8] Hanna AN, Waldman WJ, Lott JA, et al. Increased alkaline phosphatase isoforms in autoimmune diseases[J]. Clin Chem, 1997, 43(8 Pt 1): 1357-1364.
[9] 曹旬旬, 高月求, 张文宏, 等. 基于上海市住院慢性肝病患者胆汁淤积患病率的调查研究[J]. 中华肝脏病杂志, 2015, 23(8): 569-573.
文章导航

/